Knihobot

Routledge Studies in Innovation, Organization and Technology - 35: Business Modeling for Life Science and Biotech Companies

Creating Value and Competitive Advantage with the Milestone Bridge

Uložit

Parametry

  • 212 stránek
  • 8 hodin čtení

Více o knize

Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.

Nákup knihy

Routledge Studies in Innovation, Organization and Technology - 35: Business Modeling for Life Science and Biotech Companies, Alberto Onetti, Antonella Zucchella

Jazyk
Rok vydání
2018
Vazba
(měkká),
Stav knihy
Dobrá
Cena
1 099 Kč

Doručení

Platební metody

Nikdo zatím neohodnotil.Ohodnotit

Titul
Routledge Studies in Innovation, Organization and Technology - 35: Business Modeling for Life Science and Biotech Companies
Podtitul
Creating Value and Competitive Advantage with the Milestone Bridge
Jazyk
anglicky
Vydavatel
Routledge
Rok vydání
2018
Vazba
měkká
Počet stran
212
ISBN10
1138616907
ISBN13
9781138616905
Série
Anotace
Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.